Skip to main content
U.S. Department of Energy
Office of Scientific and Technical Information

Differential recovery of circulating T cell subsets after nodal irradiation for Hodgkin's disease

Journal Article · · J. Immunol.; (United States)
OSTI ID:5071937

To better understand the immunologic effects of lymphoid irradiation (LI), blood levels of T cell subsets were sequentially monitored in 15 patients before, during, and after irradiation treatment for Hodgkin's disease. Blood levels of all lymphocytes, T cells, and T cell subsets (defined by OKT4 and OKT8) fell dramatically and in similar proportions during early therapy, reaching levels less than 20 to 25% of control by the completion of mantle irradiation, and continuing at very depressed levels through the completion of therapy. Blood levels through the completion of therapy. Blood levels of OKT8-reactive (OKT8/sup +/) cells returned to pretreatment levels between 6 to 8 mo after LI, whereas blood levels of OKT4-reactive (OKT4/sup +/) cells returned to only 42% of previous values over the same period. During the recovery period, discrepancies of 208 +/- 32 cells/mm/sup 3/ (3 to 5 months post LI) and 198 +/- 32 cells/mm/sup 3/ (6 to 8 mo post LI) developed between the blood levels of OKT3/sup +/ cells and the sum of OKT4/sup +/ and OKY8/sup +/ cells. This suggests the emergence of OKT4/sup +//OKT3/sup -/, OKT8/sup +//OKT3/sup -/, and/or OKT4/sup +//OKT8/sup +/ cells. The authors concluded that LI is similarly cytotoxic to peripheral blood T cell subpopulations. The reversed ratio after LI is a result of a slower repopulation of the peripheral blood by OKT4/sup +/ cells relative to OKT8/sup +/ cells. T cells after LI show a high degree of antigenic immaturity. It is postulated that the bone marrow that lies outside the fields of treatment and contains predominantly immature OKT8/sup +//OKT3/sup -/ cells is a major source of T cells repopulating the peripheral blood after LI.

Research Organization:
General Hospital, Boston, MA
OSTI ID:
5071937
Journal Information:
J. Immunol.; (United States), Journal Name: J. Immunol.; (United States) Vol. 132:2; ISSN JOIMA
Country of Publication:
United States
Language:
English